Condensed Consolidated Balance Sheet (USD $)
In Thousands, unless otherwise specified
Mar. 31, 2014
Dec. 31, 2013
Current assets    
Cash and cash equivalents $ 55,505 $ 6,636
Marketable securities 28,018 401
Accounts receivable (net of allowance of $144 and $146 at December 31, 2013, and March 31, 2014 respectively) 4,040 6,204
Inventory 5,132 3,762
Research and development tax credit receivable short term 14,039 14,139
Prepaid expenses and other current assets 1,991 2,481
Total current assets 108,725 33,623
Goodwill, net 18,491 18,491
Property and equipment, net 17,170 17,435
Intangible assets 37,201 40,139
Other assets:    
Research and development tax credit receivable long term 0 6,410
Other long-term assets 155 154
Total assets 181,742 116,252
Current liabilities    
Current portion of long-term debt, incl to related parties 18,090 19,194
Current portion of capital lease obligations 42 85
Accounts payable 6,358 5,099
Current portion of deferred revenue 157 1,264
Advances from customers 0 116
Accrued expenses 5,165 6,527
Other current liabilities 7,485 8,310
Total current liabilities 37,297 40,595
Long-term debt, less current portion, incl. to related parties 56,570 66,320
Capital lease obligations, less current portion 120 103
Deferred tax liabilities 0 2,806
Other long-term liabilities 9,626 15,940
Total long-term liabilities 66,316 85,169
Shareholders' equity:    
Ordinary shares: 25,612,550 issued and outstanding at December 31, 2013 and 38,267,550 at March 31, 2014 (shares authorised 46,730,190) at nominal value of 0.122 euro 5,888 3,746
Additional paid-in capital 324,378 211,473
Accumulated deficit (262,184) (235,546)
Accumulated other comprehensive income (loss) 10,047 10,815
Total shareholders' equity 78,129 (9,512)
Total liabilities and shareholders' equity $ 181,742 $ 116,252